<DOC>
	<DOCNO>NCT01091753</DOCNO>
	<brief_summary>The purpose study determine effect nocturnal administration Anti-hypertensive medication Non-dippers . Efficacy variable . 1 . ECHO 2 . 24hr . horter 3 . IMT 4 . BUN/crea , urine analysis ( microalbulinuria 5 . Cardio vascular event. ``</brief_summary>
	<brief_title>Effect Nocturnal Administration Anti-hypertensive Medications NoN-dippers</brief_title>
	<detailed_description />
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>1 . Essential hypertension ( stage 12 ) 2 . 24hr . holer : nondipper 3 . Age 18 ~70 . 1 . Any known malignant disease 2 . Renal failure , creatinine &gt; 2.0mg/dl 3 . Liver disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Non-dipper HTN patient</keyword>
</DOC>